Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes

Molecular Biology of the Cell

Volumn 12, Issue 8, 2001, Pages 2352-2363

  Hennigan, R F ^a   Stambrook, P J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PONASTERONE A; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROSARCOMA; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION;

EID: 0035172076     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.12.8.2352     Document Type: Article

References (43)

1. The transactivating domain of c-Jun is required for cotransformation of rat embryo cells
2. Transforming p21ras mutants and c-ETS-2 activate the cyclin D1 promoter through distinguishable regions
3. Cell cycle-dependent variations in c-Jun, and JunB phosphorylation: A direct role in the control of cyclin D1 expression
4. Heterodimer formation between CREB and Jun proteins
5. Fos family members induce cell cycle entry by activating cyclin D1
6. Suppression of oncogene induced transformation by a deletion mutant of c-Jun
7. Mechanism of action of a dominant negative mutant of c-Jun
8. Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun
9. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation, and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity
10. A c-fos/estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines
11. Fos and Jun: The AP-1 connection
12. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate induced invasion in mouse keratinocytes
13. G1/S control of anchorage independent growth in the fibroblast cell cycle
14. Cellular transcription and malignancy induced by ras require c-jun
15. Analysis of temperature sensitive functions of Fos: Lack of a correlation between transformation and TRE dependant trans activation
16. c-Jun transactivates the promoter of the human p21WAF1/Cip1 gene by acting as a superactivator of the ubiquitous transcription factor Sp1
17. AP-1 function and regulation
18. The inhibitory activity of a transdominant c-Jun mutant fused to the ligand binding domain of the estrogen receptor
19. The Jun and Fos families are both required for cell cycle progression in fibroblasts
20. AP-1 factors play an important role in transformation induced by the v-rel oncogene
21. AP-1 mediated invasion requires increased expression of the hyaluronan receptor CD44
22. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-Ras oncogene
23. pp60v-src induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways
24. Transformation supressor activity of a Jun transcription factor lacking its activation domain
25. The transcription factor AP-1 is required for EGF-induced activation of Rho-like GTPases, cytoskeletal rearrangements, motility and in vitro invasion of A431 cells
26. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
27. Antisense RNA to the c-fos gene: Restoration of density-dependant growth arrest in a transformed cell line
28. Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle
29. Activated N-ras controls the fransformed phenotype of HT1080 human fibrosarcoma cells
30. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage
31. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents Il-2 gene transcription
32. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-Jun mutant
33. Fos associated protein p39 is the product of the Jun proto-oncogene
34. Fos and Jun bind cooperatively to the AP-1 site: Reconstitution in vitro
35. Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals
36. CIP1 and Cdc25A: Competetion between an inhibitor and an activator of cyclin-dependent kinases
37. Control of cell cycle progression by c-Jun is p53 dependent
38. Autocrine motility factor is a growth factor
39. Microinjection of transforming ras protein induces c-fos expression
40. Analysis of AP-1 function in cellular transformation pathways
41. Transcriptional repression of p21(Waf1/CIP1/Sdi1) gene by c-jun through Sp1 site
42. c-Jun regulates cell cycle progression, and apoptosis by distinct mechanisms